Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00291096 · ClinicalTrials.gov registry record
High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
A clinical trial of Breast Cancer, sponsored by Carol Fabian, MD.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT00291096 is a study of Breast Cancer that is actively recruiting participants, run by Carol Fabian, MD. The registered enrollment target is 3,000 participants, roughly in line with the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT00291096, a study of Breast Cancer, is actively recruiting participants, sponsored by Carol Fabian, MD.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as well as to develop or refine risk biomarkers which may be useful in predicting and monitoring response to prevention interventions.
Conditions Studied
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 1989-08 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00291096
The ClinicalTrials.gov registry entry for NCT00291096 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target. The listed sponsor is Carol Fabian, MD, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00291096 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT00291096 about?
NCT00291096 is a clinical study titled "High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer". The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as well as to develop or refine risk biomarkers which may be useful in predicting and monitoring response to prevention interventions.
What is the current status of trial NCT00291096?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 1989-08. Estimated completion is 2027-12.
What conditions does trial NCT00291096 study?
This clinical trial studies the following conditions: Breast Cancer.
Who is sponsoring clinical trial NCT00291096?
This trial is sponsored by Carol Fabian, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00291096 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.